IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PIZZI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.090
EU - Europa 7.786
AS - Asia 6.256
SA - Sud America 1.043
AF - Africa 138
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 17
AN - Antartide 1
Totale 26.349
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.901
PL - Polonia 3.263
CN - Cina 2.120
SG - Singapore 2.000
UA - Ucraina 1.056
BR - Brasile 854
IT - Italia 810
DE - Germania 772
HK - Hong Kong 624
VN - Vietnam 507
FI - Finlandia 422
GB - Regno Unito 375
FR - Francia 359
IN - India 329
RU - Federazione Russa 244
TR - Turchia 206
IE - Irlanda 183
CA - Canada 99
BD - Bangladesh 91
ID - Indonesia 67
AR - Argentina 61
MX - Messico 57
NL - Olanda 57
IQ - Iraq 48
JP - Giappone 47
SE - Svezia 45
BE - Belgio 44
ZA - Sudafrica 43
ES - Italia 35
KR - Corea 35
CZ - Repubblica Ceca 31
AT - Austria 27
EC - Ecuador 27
PK - Pakistan 27
CO - Colombia 25
UZ - Uzbekistan 23
VE - Venezuela 21
CL - Cile 18
KE - Kenya 18
MA - Marocco 18
IR - Iran 17
EU - Europa 16
IL - Israele 16
AU - Australia 15
NG - Nigeria 13
SA - Arabia Saudita 12
JO - Giordania 11
PE - Perù 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
TN - Tunisia 10
AZ - Azerbaigian 9
UY - Uruguay 9
ET - Etiopia 8
LT - Lituania 8
OM - Oman 8
PH - Filippine 8
DZ - Algeria 7
BO - Bolivia 6
EG - Egitto 6
JM - Giamaica 6
MU - Mauritius 6
AL - Albania 5
CH - Svizzera 5
HN - Honduras 5
LV - Lettonia 5
NP - Nepal 5
RO - Romania 5
BG - Bulgaria 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LK - Sri Lanka 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TW - Taiwan 4
CR - Costa Rica 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
SV - El Salvador 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 26.327
Salva come PNG Salva come JPEG
Città #
Warsaw 3.257
Singapore 1.046
Fairfield 1.040
Ashburn 953
Woodbridge 812
Jacksonville 732
Houston 619
Hong Kong 618
Ann Arbor 491
Chandler 474
Cambridge 441
Beijing 438
Seattle 412
Wilmington 386
San Jose 352
The Dalles 340
Princeton 315
Nanjing 298
Brescia 283
New York 270
Helsinki 256
Los Angeles 228
Dearborn 206
Dublin 182
Lauterbourg 171
Dallas 169
Istanbul 165
Council Bluffs 142
Dong Ket 126
Ho Chi Minh City 117
Munich 111
Des Moines 101
Buffalo 98
Milan 98
Nanchang 90
Chicago 89
Pune 84
Hanoi 81
São Paulo 81
Shenyang 80
San Francisco 79
Moscow 74
Hebei 71
Shanghai 70
Jinan 69
Tianjin 69
Redondo Beach 68
Lancaster 65
Changsha 61
Santa Clara 56
London 54
Orem 53
San Diego 52
Jakarta 49
Brussels 41
Phoenix 40
Chennai 36
Denver 36
Turku 35
Toronto 34
Guangzhou 33
Brooklyn 32
Kunming 32
Jiaxing 31
Hangzhou 30
Salt Lake City 30
Ningbo 29
Zhengzhou 29
Montreal 28
Tokyo 27
Amsterdam 26
Rio de Janeiro 26
Nuremberg 25
Rome 23
Baghdad 22
Lanzhou 22
Taizhou 22
Tashkent 22
Verona 22
Atlanta 21
Brasília 21
Frankfurt am Main 21
Johannesburg 21
Manchester 20
Norwalk 20
Boardman 19
Brno 19
Stockholm 19
Belo Horizonte 18
Boston 18
Mexico City 18
Mumbai 18
Orange 18
Poplar 18
Porto Alegre 18
Tampa 18
Haikou 17
Nairobi 17
Paris 17
Augusta 16
Totale 18.267
Salva come PNG Salva come JPEG
Nome #
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid 370
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 362
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia 325
Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubes. 317
1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 317
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation 314
Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates 311
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. 311
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 307
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 303
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. 301
Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle 296
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. 294
A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia 284
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases 283
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 275
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model 271
Mild inflammatory profile without gliosis in the c-rel deficient mouse modeling a late-onset parkinsonism 266
The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging 262
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 260
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke 257
1,2,4-Triazine derivatives as agents for the prevention of AGE-RAGE-mediated inflammatory cascade in THP-1 monocytes: An approach to prevent inflammation-induced late diabetic complications 246
Pharmacological targeting of the beta-amyloid precursor protein intracellular domain 238
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 218
NUOVO IMPIEGO TERAPEUTICO PREVENTIVO DELLA SUBUNITA' C-REL DELLA PROTEINA NF-KAPPAB E NUOVO IMPIEGO DI UN ANIMALE TRASGENICO NON UMANO CHE PORTA LA DELEZIONE DEL GENE C-REL (C-REL-/-) 214
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 209
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 205
Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival 203
The gamma-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease 198
The Role of Mast Cells in Stroke 198
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability 196
Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. 196
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 196
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 195
c-Rel deficient mice, a mouse model of "spreading" PD-like pathology. 194
NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. 193
Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. 192
Spinal cord mGlu1a receptors - Possible target for amyotrophic lateral sclerosis therapy 187
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 187
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. 182
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 181
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 176
A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. 174
Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. 174
The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation 172
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE 170
c-Rel deficient mice, a mouse model of “spreading” PD-like pathology 166
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. 165
Synapsin III alterations in Parkinson's disease 165
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 163
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia. 160
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 160
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 158
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke. 158
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. 158
Degenerazione età –dipendente dei neuroni dopaminergici della sostanza nera nei topi NF-kappaB cRel 154
Acetylation of NF-kappaB p50/RelA and histones in the epigenetic regulation of pro-apoptotic transcription: a neuroprotective target in brain ischemia 152
Cortical neurons induce the expression of glutamate receptors in primary myotubes 152
A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. 151
SYNERGIC ROLE OF RESVERATROL AND HDACi MS-275 IN NEUROPROTECTION 151
Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats. 151
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 150
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 150
Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells 146
Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. 143
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 143
Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death 142
Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. 141
An in vitro method of diagnosing Parkinson's disease 141
Synapsin III Alteration in Parkinson's disease 141
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 140
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. 140
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 140
Pharmacological basis for dopamine D-2 receptor diversity 139
CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease. 138
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats 138
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro 138
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 138
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. 138
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 137
Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. 136
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 136
A soluble interleukin-6 (IL6) recepetor/IL6 fusion protein enhances the in vitro differentiation of purified rat oligodendroglial lineage cells 136
From preclinical stroke models to humans: Polyphenols in the prevention and treatment of stroke 136
Synapsin III Alteration in Parkinson's disease 134
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 134
Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments 133
NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production 132
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation 132
Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy. 132
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 131
DIVALENT METAL TRANSPORTER 1-DEPENDENT ISCHEMIC NEURODEGENERATION: STRATEGIES TO KNOCKDOWN FERROUS IRON UPTAKE 131
Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. 129
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 128
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 128
The inhibitor of IkappaBalpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices. 127
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders 127
NF-kappaB dimer heterogeneity: a molecular determinant of neuron vulnerability in post ischemic brain damage 126
NF-κB unbalance and dysfunction in acute and age-related neurodegenerative disease 126
Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices 125
Totale 18.846
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021732 0 0 0 0 0 0 0 0 0 267 279 186
2021/20221.396 121 272 25 37 25 64 87 77 70 181 129 308
2022/20231.311 187 34 56 102 134 329 3 132 192 27 58 57
2023/20241.384 92 34 120 82 68 325 55 66 276 31 33 202
2024/20253.480 24 44 34 408 344 208 335 122 513 164 864 420
2025/20266.781 707 896 551 1.048 745 566 1.068 331 435 434 0 0
Totale 26.923